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It has become increasingly clear that there are additional mechanisms to the sliding 
filament theory that contribute to the contractile properties of smooth muscle. It has 
been suggested that remodelling of the cytoskeleton may explain the unique 
contractile properties exhibited by smooth muscle. There has been previous evidence 
of differential remodeling of the alpha- and beta-actin as well as smooth muscle 
myosin II cytoskeletal structures. However, the mechanism(s) regulating this 
differential remodeling are not understood. Previous experiments have demonstraed 
that inhibition ofRho'kinase has been ~hown to decrease force development in 
contracting aortic smooth muscle tissue. We wanted to test the hypothesis that 
inhibition of Rho kinase would alter alpha-actin remodeling and podosome formation 
in A 7r5 smooth muscle cells. A 7r5 cells stimulated with 10-8M PD Bu demonstrated 
remodeling of the alpha-actin cytoskeleton with a partial loss of actin cable structure 
and formation of podosomes. Cells were treated with the specific Rho kinase 
inhibitor Y-27632 at three different concentrations (lµM, 0.1 µM, and lnM) either 
before or after stimulation with I 0-8 M phorbol ester (PD Bu). Cells treated with 
Y-27632 before stimulation with PDBu did not undergo normal alpha-actin 
remodeling. Podosome formation was abolished, and there was loss of actin cable 
structure. In precontracted cells treated with Y-27632, podosome structure was lost 
and the alpha-actin fiber structure was lost. The results indicate that the inhibition of 
Rho kinase prevents remodeling of the alpha-actin cytoskeleton and may play a 
significant role in smooth muscle forci; generation. To observe the effect of 
inhibition Rho kinase in resting cells, A7r5 ells were exposed to lnM ofY-27632 for 
5 , 10, 20, 30, and 40 minutes. After five minutes of exposure, disruption of the 
a.-actin cytoskeleton was evident with an almost complete disruption of cable 
stucture by 40 minutes exposure. This data suggests that Rho kinase activity is also 
required for a.-actin bundling into fibers in the resting cell. Taken together it is 
apparent that Rho kinase is an essential enzyme in regulating alpha-actin dynamics in 
the A 7r5 smooth muscle cell. 
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INTRODUCTION 
' . 
This project was designed to enhance our understanding of possible additional 
. . ·~ 
mechanisms to the sliding filament theory that contributes to the unique contractile 
. ~ .. ' 
properties of smooth muscle, by the utilizati~n of immunochemistry techniques. The 
protocols have allowed us to examine the effects of inhibition of Rho kinase in 
smooth muscle cell a-actin remodeling and how it could have an effect upon the 
contraction of smooth muscle. This study investigated the hypothesis that inhibition 
of Rho kinase will prevent a-actin reorganization in the A7r5 smooth muscle cell. 
The objective of the experimental design was to determine ifby inhibition of Rho 
kinase there is an affect on the organization of a-actin into podosomes. 
Smooth Muscle Function 
Smooth muscle tissue is found in several organ systems within the body: 
gastrointestinal, reproductive, ocular, respiratory, urinary and vascular. Smooth 
muscle is named for the lack of visible striations within the tissue. Functions of 
smooth muscle include: controlling the diameter of blood vessels, the movement of 
food along the gastrointestinal system, homeostatic function within the reproductive 
tract, the ocular system, and the arrector pili in the skin. A common function of 
smooth muscle is for transport or storage. It does not function as a rigid conduit for 
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transport. This is illustrated through the dynamic contractile/relaxant response of 
vascular smooth muscle during the regulation and maintenance of blood pressure. 
Smooth muscle develops tension slowly and is capable of maintaining tension for a 
long period of time (Figure 1). This is in contrast to skeletal muscle which is unable 
to maintain tension for an extended period of time. The energy level that is required 
to maintain tension in smooth muscle occill;l at about 0.35% of a tetanized striated 
muscle (Paul, 1983). 
Sliding Filament Theory 
Myosin and actin are present in both smooth and skeletal muscle; both 
proteins are associated in a complex structure called, actomyosin. The organization 
and properties of both myosin and actin within the muscle are utilized for contraction 
and relaxation of muscle, and occurs in a similar mechanism in both smooth and 
skeletal muscle as described by the sliding filament theory (Marston and Smith, 
1985). The sliding filament theory _describes how myosin and actin interact by a 
cross-bridge formation (Figure 2). The myosin heads that project from the thick 
filaments briefly attach to a binding site on an adjacent actin filament. Driven by 
ATP energy strokes, myosin heads will pull the actin filament along with them 
toward the center of the sarcomere. The sarcomere will shorten as the actin filaments 
slide towards its center (Starr and Taggart, 2001). Although both muscle types are 
signaled to contract by an increase in the intracellular calcium, the subsequent 
biochemical pathways are different (Figure 2 and Figure 3). 
3 
0 
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Smooth Muscle Contraction 
---- ----------------------------
Skeletal Muscle Contraction 
Figure 1: Typical contraction demonstrating the differences between smooth 
and striated muscle. 
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Increase in intracellular Calcium 
T ropomyosin shifts out of Resting Position on Actin Helicies 
Disinhibition of Actin Myosin Interaction 
Myosin/ Actin Binding 
Myosin A TPase Activated 
Crossbridge Formation and Cycling 
Figure 2. Sliding filament theory of muscle contraction. 
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Smooth Muscle Structure 
Smooth muscle has a single nucleus with a wide peripheral zone of cytoplasm 
which is dominated by myofilament bundles that are associated with dense bodies 
(Thyberg et al., 1985). The spindle shaped cells in smooth muscle are composed of 
thick and thin filaments which are not organized into well-ordered sacromeres, as 
they are in skeletal muscle; thus the term smooth muscle. Thin filaments have three 
functions within smooth muscle: (1) force generation by interaction with the protein 
myosin (2); control of force generation by interaction with regulatory molecules (3); 
and transmission of force to the ends of the cell to produce contraction of the muscle 
as a whole, by organization of actin into filament arrays and attachment to the cell 
surface (Marston and Smith, 1985). The thin filament is composed of a double helix 
of actin monomers, with monomers repeating every 5.9 nm and the helix completing 
one full turn every 74 nm (Marston and Smith, 1985). Thin filaments arrange in 
parallel tracts along the cell length in the relaxed smooth muscle. The filaments 
gather in loose bundles, which will attach to the dense bodies. Actin filaments may 
be arranged in a dense bundle that allows for 15 actin filaments to interact with each 
myosin filament in smooth muscle (Marston and Smith, 1985). In smooth muscle, the 
actin-binding protein a.-actinin is present; as well as the actin binding protein 
vinculin, which is not found in the Z disks in skeletal muscle. Vinculin will bind to 
the integral membrane directly in the plaque and also to the a.-actinin, which then 
attach to the actin filaments to the membrane adhesion sites (Alberts et al., 2002). 
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The actin binding and crosslinking activities of a.-actinin are influenced strongly by 
the presence of other actin binding proteins and are also temperature-dependent 
(Schloss and Goldman, 1979). 
Actin Cytoskeleton Dynamics , 
' 
The actin cytoskeleton is an imporll!Jlt structure that contributes to cell-cell 
. . . 
and cell-substrate interactions providing a structural framework by modulating signal 
transduction cascades (Yin and Stull, 1999). It is also involved with many of the 
fundamental cell processes, such as lamellipodial and growth cone extension, 
chemotaxis, endocytosis, exocytosis, and cytokinesis. Adding monomers to the 
barbed end of an actin nucleating site near the membrane and depolmerizing deeper 
within the cytoplasm of the actin filament causes the dynamic nature of an actin 
filament. This process involves the regulation of many proteins. Actin nucleation 
requires additional proteins. Actin related protein, Arp2/3 will cap the pointed ends 
of the actin, and initiate polymerization on the barbed end (Yin and Stull, 1999). 
Proteins in the Wiskott-Aldrich syndrome protein family, (WASp) stimulate 
nucleation by Arp2/3 and the small GTPase, Cdc42, and PIP2, This will then increase 
the activity of some WASp proteins (Yin and Stull, 1999). Subsequently, the barbed 
ends are produced by the cutting of preexisting actin filaments to create an exposed 
barbed end. This may be performed by gelsolin which is an actin severing protein 
activated by Ca2+. Gelsolin uncapping and barbed end elongation may be promoted 
by PIP2 and Rae. In addition, the barbed ends of actin may be exposed by the 
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removal of capping proteins such as CapG (Yin and Stull, 1999). In order for rapid 
actin polymerization to occur on the leading edge (the barbed end), depolymerization 
must occur somewhere else to maintain the supply of G-actin monomers for addition 
to the growing F-actin. ADF/cofilin promotes actin filament depolymerization by 
severing and promoting actin fiber breakdown (Yin and Stull, 1999) and may provide 
a pool of available actin monomers. Actin filaments which are polymerized may 
form a scaffold-like structure near the plasma membrane using ERM cross-linking 
proteins. The ERMs are composed of the proteins ezrin, radixin and moesin and play 
an important role in organization of the cortical actin network and mediating 
membrane/cytoskeletal cross-talk. The ERM proteins are activated by PIP2 through a 
Rho-dependent pathway, and ERM conformation is maintained by phosphorylation 
(Yin and Stull, 1999). 
Polymerizable ATP-actin consists of free ATP-G-actin and complexes of 
ATP-G-actin with profilin or with functional homologs of profiling like WH2-domain 
proteins of the actobindin family (Carlier and Pantaloni, 2007). The WH2-domain 
proteins bind with G-actin and participate in the barbed end assembly, profilin and its 
functional homologs will also "play a role in the assembly. The ATP-G-actin 
polymerization is determined by the overall flux of pointed end depolymerization and 
by the number of barbed ends_ (Carlier and Pantaloni, 2007). 
Smooth muscle contains two actin isoforms, the ~-actin filaments that are 
structural, and the a-actin filaments that associate with myosin and are involved in 
contraction (Yin and Stull, 1999). 
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Smooth Muscle Role of Myosin 
Myosin present in smooth muscle may be only 20% of skeletal muscle 
(Murphy et al., 1974; Murphy 1976). Myosin containing filaments help to generate 
tension that may occur during a muscle contraction. The myosin molecule appears as 
a structure ranging in length to approximately 150nm long, consisting of two globular 
heads and a single tail. Myosin molecules found in smooth muscle consist of six 
polypeptide chains. The chains include two heavy chains, two regulatory chains, and 
two essential alkali light chains. The two heavy chains will come together and form a 
dimer, which comprises the main body of the molecule. The heads of the myosin 
molecule will form the cross-bridges with actin. Motor activity is contained within 
the head, and it is here that we find the ATP and actin binding sites. Each head 
consists of a heavy chain of about 2,000 amino acids and has two light chains 
attached to it (McComas 1996). There are three components of the globular head, 
with the molecular weight of 20 kDa, 25 kDa, .and 50 kDa. The two light chains will 
attach to the 20 kD subunit, while the 50 kDa subunit contains the ATP hydrolyzing 
site, a well as sites for attachment to actin (McComas 1996). The tail is formed by 
two a-helices that will coil around each other and myosin molecules will associate 
together so that several hundred can form a single myosin filament. The structure of 
the tail also allows for each of the myosin molecules within the filament to face away 
from the other half(McComas 1996). 
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Myosin Light Chain Kinase 
Differences in the structure and contractile protein content in both smooth and 
skeletal muscle suggest that there may be mechanisms in smooth muscle in addition 
to sliding filament which provides a biochemical or mechanical advantage during 
smooth muscle contraction. The stimulation of smooth muscle will result in the rise 
of intracellular calcium which will lead to tlie activation of the calcium binding 
protein, calmodulin: Calmodulin will activate the myosin light chain kinase with the 
resulting phosphorylation of Ser 19 on myosin light chains. After phosphorylation 
occurs, myosin ATPase activity, and subsequent myosin/actin crossbridge formation 
and cycling will occur. It has been shown that slow force development, maintenance 
of tension (Driska et al., 1981 ), and velocity of shortening (Merkel et al., 1990) are 
disassociated from the myosin light chain phosphorylation and myosin ATPase 
activity (Zhang and Moreland, I 994) in smooth muscle. A contraction that has been 
induced by phorbol ester may occur in the absence of a detectable increase of 
intracellular Ca2+ or concomitantly increased myosin light chain phosphorylation 
(Nakajima et al., 1993). It has been shown that myosin light chains affect the actions 
of the myosin heads, possibly modifying the rate of movement in each power stroke 
(Nakajima et al., 1993). Phosphorylation of the myosin light chain has been proposed 
as the mechanism responsible for potentiating isometric twitch tension (Nakajima et 
al., 1993). Increasing Ca2+ within permeable cells will increase the extent of the 
myosin light chain phosphorylation. (Figure 3). 
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Increase in Intracellular Calcium 
Calcium/Calmodulin Complex 
Phosphloration of Myosin Light Chain Kinase (MLCK) 
Phosphorylation of Serine 19 of Myosin Light Chains 
Activation of Myosin ATPase 
Figure 3: Traditional biochemical pathway of smooth muscle 
contraction. 
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Signal Transduction Pathways in Smooth Muscle 
Smooth muscle cells may be able to adjust their functional properties by 
reorganizing their cytoskeleton and also by altering signaling pathways which 
regulate contractile protein activation and function (Gerthoffer and Gunst, 2001). 
The signaling pathways seem to mediate these adaptive responses of the cytoskeleton 
to be integrated with the pathways which regulate gene expression, cell phenotype, 
and protein synthesis. This suggests that the immediate adaptive responses of smooth 
muscle cells may proceed or initiate a modification of a longer time frame in cell 
phenotype and tissue structure. Signal transduction pathways to the actin 
cytoskeleton are present in differentiated smooth muscle tissues, and it is these 
pathways which may be important in adapting the structural organization, phenotype, 
and contractile properties of the tissues to external forces, allowing for the smooth 
muscle tissues of hollow organs to respond to a changfr1g environment. Actin 
remodeling is required for cell migration to occur during development and also in the 
proliferative response to injury in the smooth muscle (Gerthoffer and Gunst, 2001). 
Integrins 
Within the smooth muscle cells, the integrins are found to be localized to 
membranes associated with electron dense plaques. This is where tension 
transmission between the contractile apparatus and extracellular matrix may occur 
(Shaw et al., 2002). At the membrane associated dense plaques, actin filaments will 
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attach to transmembrane integrins by a series of linker proteins that include talin, 
vinculin, cx.-actinin, as well as various kinases and signaling proteins. Integrins and 
focal adhesion proteins, including F AK, Src family tyrosine kinases and paxillin, may 
function as factors in this signaling pathway (Gerthoffer and Gunst, 2001 ). The 
superfamily ofras-related small G proteins can be divided into three subfamilies: 
Rho, Rae, and Cdc42 [vv ang and Bitar, 1998) and may play an important role in 
coupling mechanotransduction pathways to actin remodeling (Gerthoffer and Gunst, 
2001). 
Rho-kinase 
Rho-kinases are serine/theronine kinases with a molecular mass of 
approximately 160 kDa and are expressed in both invertebrates and vertebrates 
(Loirand et al., 2006). The gene for Rho-kinase in humans is located on chromosome 
12, and codes for a protein of 1,388 amino acids (Noma et al., 2006). Rho-kinases 
are distributed mainly in the cytoplasm and are activated by the GTP-bound RhoA, 
undergoing translocation from the cytoplasm to the membrane (Noma et al., 2006). 
Rho-kinase has been implicated in actin dependent functions, such as cell motility, 
formation of stress fibers, and focal adhesions, organization of the actin cytoskeleton, 
and smooth muscle contraction (Shabir et al., 2004). Rho is activated by Rho-kinase 
which may function in smooth muscle as a signaling molecule, activating a 
mechanism that sensitizes the contractile machinery to Ca2+ (Shabir et al., 2004). The 
main physiological effect of Rho- kinase is the ability to enhance actin-myosin 
- 13 -
association by increasing MLC phosphorylation and by preventing actin 
depolymerization (Norma et al., 2006). 
Inhibiting Rho-kinase has been found to reduce the plateau component of the 
action potential, inhibiting the Ca2+ channels and also indirectly the Ca2+ activated er 
channels (Shabir et al., 2004). Inhibition of Rho-kinase produces a Ca2+ independent 
increase in the relaxation rate of muscle contraction. 
Rho-kinase isoforms have been used to investigate in vivo distribution and 
function through knockout mice. 'The loss of Rho-kinase in knockout mice resulted in 
placental dysfunction leading to intrauterine growth retardation and fetal death 
(Loirand et al., 2006). Mice that survived were found to undergo normal 
development and were fertile (Loirand et al., 2006). In pressurized small arteries, the 
use of Rho-kinase inhibitors has showed that the Rho-kinase pathways are active in 
the absence of vasoconstrictors, acting to keep the vessels in a state of high calcium 
sensitivity and basal tone (Loirand et al., 2006). The present knowledge ofRho-
kinase signaling has suggested that pharmacological agents which target Rho-kinase 
may have a therapeutic benefit in reducing cardiovascular disease (Loirand et al., 
2006; Noma et al., 2006). 
Rho-A and HSP27 
Rho A has been found to regulate smooth muscle contraction through 
cytoskeletal reorganization of the low molecular weight HSP27 identified as an actin 
binding protein. In a variety of tissues HSP27 is expressed in the absence of stress 
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and it has been suggested to have a phosphorylation-activated homeostatic function at 
the actin cytoskeleton level (Wang and Bitar, 1998). In cells affected with dominant 
negative Rho A, experiments with ceramide or endothelin suggested that Rho A may 
exert its effects on the cytoskeletal reorganization by HSP27 (Wang and Bitar, 1998). 
The requirement of Rho A for HSP27 red(strib,ution may be linked to the interaction 
' ., 
between cytoskeletal proteins which are sustained within a smooth muscle 
. ,, ' ' ' " 
contraction. 
Y-27632 
The inhibitor Y-2763 was used to analyze the involvement of Rho and Rho-
associated kinase in the organization ofF- actin cytoskeleton within T-cells 
(Rodriguex-Fernandez et al., 2001). It was found that the inhibitor Y-2763 affected 
only the organization of the F-actin; in T-cell the total actin levels were not altered 
(Rodriguex-Fernandez et al., 2001). The effect of the inhibitor on the cytoskeleton 
was selective as the microtubules were not altered (Rodriguex-Fernandez et al., 
2001). 
Y-27632 has been found to inhibit the Rho family ofkinases 100-fold more 
potently than other kinases including protein kinase C, cAMP-dependent kinase, and 
myosin light chain kinase (Ishizaki et al., 2000). It has been found that Y-27632 
inhibits the Rho-kinases by competing with ATP for binding to the kinases, however 
Y-27632 can exert specific effects at a lower µM concentration within the cells 
because ATP is present within the cell at millimolar concentrations (Ishizaki et al., 
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2000). The competition between inhibition kinetics suggests that millimolar 
concentrations ofY-27632 is required in order to inhibit the kinase activity of Rho in 
situ within the cell (Ishizaki et al., 2000). 
Y-27632 has also been used to investigate the expression of the two isoforms 
of Rho-kinase and its role in the pathophysiological control of smooth muscle 
contraction in rabbits. The use ofY-27632 considerably suppressed the ureter 
contractile responses within the rabbits (Rodriguex-Femandez et al., 2001). 
Inhibitors of Rho-kinase such as Y-27632 will have similar effects compared to 
dominant-negative mutants ofRho-kinases, causing a loss of actin stress fibers and 
focal adhesion complexes (Noma et al., 2006). This action is believed to be due to 
phosphorylation and inhibition ofMLCP by Rho-kinases, which increase MLC 
phosphorylation and cellular contractions by increasing interaction ofmyosin with 
actin (Ishizaki et al., 2000). 
When Y-27632 was used to examine in the role of Rho-kinase in cytokinesis, 
it was found that concentrations greater than 100 µM were required for significant 
inhibition. However, inhibition.did demonstrate damaging effects upon the cells 
(Ishizaki et al., 2000). 
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Functions of the Extracellular Matrix in Smooth Muscle 
Cells contact the extracellular matrix through a variety of specialized 
structures. Contact with the extracellular matrix contact allows for cell adherence and 
migration. The extracellular matrix also acts as a relay station for important signaling 
pathways. Integrin proteins bind both matrix components and cellular proteins, 
connecting the extracellular environment and the cytoskeleton (Linder and Kopp, 
2005). Proteins embedded in a ring structure of integrins and integrin associated 
proteins have been named podosomes. 
Podosomes 
Podosomes are structures that have a half life of 2-12 minutes within the cell. 
The podosome structure is composed of a ring and core which are linked by bridging 
molecules such as o.~actinin, and the whole structure is surrounded by a cloud of 
monomeric actin molecules (Linder and Kopp, 2005). The stability of the structure is 
found in the core component of the podosome which is rich in F-actin. Also found 
within a podosome are actin regulators of the Wiskott-Aldrich Syndrome protein 
(WASP) family, Arp 2/3 complexs, cortactin and gelsolin. Gelsolin has been found 
to contribute to the actin turnover through its ability to both sever and cap actin 
filaments (Chellaiah et al., 1998). F-actin will turn over 2-3 times during the life span 
of the podosome. The ring structure is composed of plaque proteins such as vinculin 
or talin, and kinases such as PBK or Pyk2/F AK (Linder and Kopp, 2005). Integrins 
that are anchored in the extracellular matrix are distributed over the whole outer 
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surface of the podosome, but show isotype-specific localization: ~ 1 integrins will 
localize mostly to the core, and ~2 and ~3 will localize to the ring (Linder and Kopp, 
2005). 
Podosomes are usually found in cells of the monocytic lineage, such as 
macrophages, osteoclasts, or immature dendritic cells. They also may be found or 
induced in a variety of other cell types such as endothelial cells, and smooth muscle 
cells (Linder and Kopp, 2005). Since podosomes are formed on a soft substrate, they 
are believed to be physiological structures that are formed in the context of tissue 
(Linder and Kopp, 2005). A cell will usually form dozens ofpodosomes, with a 
diameter of0.5-1 µMand a depth of0.2-4 µM. Individual podosomes are motile 
within a certain radius, but movement of a podosome group is accomplished through 
the dynamic assembly at the front and disassembly at the rear (Linder and Kopp, 
2005). 
The main function ofpodosomes appears to be adhesion, because they 
establish close contact to the substratum. Podosome-type adhesion is mostly formed 
in cells that have to cross tissue boundaries such as monocytes, immature dendritic 
cells or some types of cancer cells (Linder and Kopp, 2005). Podosomes may also be 
involved with cell migration. They may help with localized anchorage, stabilizing 
sites of cell protrusion and enabling productive directional movement. 
A variety of cellular signaling pathways influence podosomes. The major 
modes ofpodosome regulation include signaling by Rho family GTPases, actin 
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regulatory pathways, protein tyrosine phosphorylation, and the influence of the 
microtubule system (Linder and Kopp, 2005). 
Within the Rho GTPases Rho A, Rae 1, and CDC42 have all been found to 
regulate podosome turnover within various cells, with their particular mode of action 
depending upon the cell type. 
Podosome type adhesions can be induced by the transformation of cells with 
viruses whose oncongenes encode tyrosine kinases such as v-Src . Cellular tyrosine 
kinases such as Src and Csk have a major role in podosome regulation (Linder and 
Kopp, 2005). 
A7r5 Cell Line: 
The A7r5 fibroblast cell line was derived from the smooth muscle tissue 
excised from the thoracic aorta of a rat embryo. The A7r5 cells produce muscle-type 
isoenzymes, which include myokinase and creatine phosphophokinase. The 
fibroblast produces myosin, and the activity of the isoenzymes will increase when the 
culture of the A7r5 cells reach a stationary phase (Kaverina et al., 2003). The A7r5 
cell line displays prominent stress fibers and focal contacts, and has also been shown 
to respond to contractile stimuli (Kaverina et al., 2003). It was found that when 
remodeling the a-and ~-actin domains within the A 7r5 smooth muscle cells during 
PDB-induced contraction, suggests that remodeling plays a role in contractile 
function (Fultz et al., 2002). 
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A7r5 smooth muscle cells that were induced to contract with PDBu 12, 1, and 
visualized with beta-actin EGFP, were shown to express densely packed actin stress 
cables, which were arranged in parallel and extended formation across the cell body 
(Fultz et al., 2003). The PDBu caused 85% of the cells to undergo contraction while 
showing evidence of forcible detachment from peripheral adhesion sites (Fultz et al., 
2003). 
A7r5 Cells and Podosome Formation 
Podosome initiation and maintenance in A 7r5 cells require Arp2/3 dependent 
actin polymerization and occur preferentially in the cell periphery (Kaverina et al., 
2003). Dynamic actin remodeling may possibly occur within the central region of the 
podosome. Phorbol ester is found to trigger the conversion of focal adhesions into 
podosomes within the A 7r5 smooth muscle cells (Kaverina et al., 2003; Fultz et al. 
2002). The outer region of the stress fiber bundle will form podosomes, at 
specialized sites that are embedded into adhesion plaques at the basal surface of the 
plasma membrane, and cortactin will reside constitutively at the microdomains 
(Kaverina et al., 2003). 
Rat smooth muscle cells will change from spear shaped to rosette like 
podosomes when given PDBu(Kaveria, et al., 2003). This process can be blocked by 
specific inhibitors such as PKC and Src (Hai et al., 2003; Brandt et al., 2002) and is 
regulated tightly by smooth muscle specific proteins of the calponin family, which 
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may act to suppress podosome formation in normal smooth muscle tissue (Kaverina, 
et al., 2003). 
Podosomes are representations of hot spots where there is a high actin 
turnover in smooth muscle and monocytic cells, and formation of newly polymerized 
actin filaments requires delivery ofG-actin subunits to the site of polymerization 
(Kaverina, et al., 2003). 
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METHODS 
Cell Culture Procedure: 
A 7r5 cell line, harvested from embryonic rat aorta and shown to exhibit adult 
smooth muscle characteristics (Kaverina et al., 2003), was purchased from American 
Type Culture Collection (Manasass, VA). Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 10% Fetal Bovine Serum (FBS), 100 units/ml penicillin 
G, and 100 µg/ml streptomycin (Sigma) was used to culture the cells. The cells were 
grown to approximately 85% confluence after being plated onto 75 mm2 culture 
flasks. The cultures were maintained in a Napco incubator at 37 degrees Celsius 
within a humidified atmosphere of 5% CO2 in air. Media was changed every two 
days, with the cells split at least once a week. The splitting of A 7r5 cells required a 
solution of Phosphate Buffer Saline (PBS) and Trypsin EDTA (5 g/100 ml) 
(Invitrogen), prepared·at'a 9:1 ratio. The PBS solution yvas prepared by autoclaving 2 
PBS tablets (Sigma) in 400 ml of distilled water. The trypsin solution was added to 
the cells, following the aspiration of culture medium, and incubated for 10 minutes at 
37 degrees. Frequently the flasks were agitated against the palm of hand, in order to 
enhance the stripping of cells from the flask. The cells were transferred to 15 ml 
conical tubes and centrifuged for 10 minutes. The supernatant was discarded and the 
pellet was resuspended in 3 ml ofDMEM. After resuspension, approximately 1 ml of 
the resuspended cells.was added to new flasks possessing 24 ml of the DMEM, and 
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placed into the incubator at 3 7 degrees Celsius with 5% CO2• The cells were fed with 
10% FBS supplemented DMEM every two days. 
Visualization of alpha-actin: 
The A7r5 cells were plated onto 22 mm by 22 mm #1 glass coverslips, which 
were placed into 6 well culture plates, and returned to the incubator for a minimum of 
24 hours to allow for cell attachment and spreading. After treatment, cells were fixed 
and permeabilized by adding ice cold acetone for 1 minute. The cells underwent 
multiple washings (3X), with phosphate-buffered saline supplemented with 1 % 
Tween (PBS-T), and were incubated for 10 minutes in the blocking solution (5% 
nonfat dry milk in PBS-T). The cells were then washed multiple times (3X), with 
PBS-T for 5 minutes. Monoclonal smooth muscle anti-a actin antibody (clone 1A4, 
Sigma) at a 1: 1000 dilution was added for one hour to the cells. After incubation the 
monoclonal smooth muscle anti-a actin antibody was collected and saved for further 
use. After exposure to the antibody, the cells then underwent multiple washings with 
PBS-T for 5 minutes. Cover slips were then mounted on the glass slides (Fisher) 
using Gel Mount (BioMedia) and then stored in the dark at 4 degrees Celsius until 
observed. Slides were visualized using an Olympus 1X71 inverted fluorescent 
microscope equipped with a RETIGA EXI FAST 1394 CCD camera. Images were 
captured and analyzed utilizing IP lab software (Scantalytics, Fairfax, VA). Images of 
the stained cells were captured at 500 millisecond exposure using the IP lab software 
(Figure 4). 
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PDBu stimulation of A7r5 cells 
To stimulate the contraction of the A7r5 cells and podosome formation, PDBu 
was added to each well to a final concentration of 10 -sM (Figure 5). Phorbol ester 
was initially dissolved in DMSO and then diluted to working concentration with 
distilled water. Cells were then fixed and stained as described above. 
Effect ofY-27632 on resting A7r5 cells 
To determine the effect of Rho kinase inhibition on resting A7r5 smooth 
muscle cells, Y-27626 (lOµM) was added to resting cultures of A7r5 cells for 40 
minutes (Figure 6) before fixation and staining for alpha actin. 
Effect ofY- 27632 on precontracted A7r5 cells 
A 7r5 cells were seeded onto coverslips as described above. Cells were treated 
with 10 -SM PDBu for 20 minutes to allow for contraction and podosome formation. 
Three separate concentrations ofY-27632 were then added to wells in final 
concentrations of lµM, 0.lµM, and lnM for twenty minutes. Cells were then fixed 
and stained (Figure 7). 
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A7r5 eel treatment 
Cells were fixated with ice cold acetone for 1 
minute and blocked with milk 
l 
Washed 3x with PBS-T 
' . 
. ,. ··1· '•. , 
. . ' . 
Primary anti-a-actin antibody added 1 hour 
l 
Washed 3x with PBS-T 
l 
Cover slips mounted with Gel Mount 
l 
Cover slips stored for 24 hours in dark at 4 degrees Gers 
Cover slips were visualized using Olympus 1X71 inverted 
fluorescent microscope 
Figure 4. Antibody staining protocol for visualization of alpha-actin. 
PDBu 10-8M 
20 Minutes 
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Fixed and 
Stained 
Figure 5. Protocol outline for PD Bu stimulation of A 7r5 cell line. 
Y-27632 1'0~8M . ' Fixed and 
Stained 
Figure 6. Protocol outline for Rho-kinase inhibition in unstimulated A 7r5 smooth 
muscle cells. 
PDBu 10-8M 
20 Minutes • 
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Y-27632 1 o-8M Fixed and 
Stained 
Figure 7. Protocol outline for PD Bu and inhibitor stimulation of A7r5 cell line, 
examining the effects ofY-27632 on precontracted A7r5 smooth muscle 
cells. 
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Y-27632 pretreatment with additional PDBu treatment following 
A 7r5 cells were seeded onto coverslips as described above. Cells were treated 
with either lµM, 0.lµM, and lnM ofY-27632 for 20 minutes to allow for inhibition 
of Rho kinase before stimulation with IO -sM PDBu for 20 minutes (Figure 8). Cells 
were then fixed and stained. 
Time course for the effect ofY-27632 on the resting a-actin cytoskeleton 
A 7r5 cells were seeded onto coverslips as described above. Cells were treated 
with lnM ofY-27362 for 5, 10, 20, 30 or40 minutes to allow a timecourse 
visualization of the effects of Rho kinase on the resting A7r5 cell (Figure 9). Cells 
were then fixed and stained. 
Data Analysis 
Each experiment was performed a minimum of three times with at least 50 
cells from fixed preparations that were evaluated prior to the experiment. The 
statistical data was analyzed by a two way ANOV A followed by a Students t-test. P 
< 0.05 was considered significant. 
Y-27632 
10-8M 
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PBDu 10-8M 
20 Minutes 
Fixed and 
Stained 
Figure 8. Protocol outline for A7r5 smooth muscle cells pretreated with Y-27632 
before stimulation. 
Y-27632 1 o-8M 
5, 10,20,30, or 40 Minutes 
Fixed and 
· Stained 
Figure 9. Protocol outline for A7r5 smooth muscle cells treated with Y-27632 before 
stimulation at timed intervals of 5, 10,20,30 or 40 minutes. 
- 29 -
RESULTS 
Podosome formation in A 7r5 cells 
To verify that our cell culture techniques allowed the A7r5 cell line's a-actin 
to form podosomes, cells were stimulated with PD Bu for 20 minutes. The results 
confirmed that podosome formation occurred within the cells when stimulated with 
PDBu, as seen in Figure 10. Podosome formation was observed within the A7r5 cell 
line in greater than 90% of the cells. In vehicle control A7r5 cells 8 ± 3.19 % of the 
cells demonstrated podosomes formation while 94.2 ± 16% of the A 7r5 cells 
stimulated with 10·8M PDBu demonstrated podosomes formation (p<.01) 
Criteria for determining ifpodosomes existed within the cell was established 
if the a-actin developed into structural posts that were seen in a circular pattern 
throughout the cell. The top left panel in Figure 14 illustrates typical podosome 
formation within the A 7r5 smooth muscle cell. 
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Control 
p < .01 
PBDu 
10-aM 
Figure 10. Alpha-actin remodeling and podosome formation in A 7r5 cells. Data is 
expressed as mean percent of cells undergoing a -actin remodeling and 
podosorne formation. 
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Inhibition ofpodosomes with Y-27632 pretreatment 
A7r5 cells were pretreated for twenty minutes with Y-27632 inhibitor with 
concentrations of lµM, 0.lµM, lnM. PDBu was then added to the cells at a final 
concentration of 1 o-8M to stimulate actin remodeling and podosomes formation. 
A7r5 cells that were pretreated for 20 minutes with lµM Y-27632 demonstrated 7.3 
± 1.76 % podosomes formation (Figure 11). A7r5 cells that were pretreated for 20 
minutes with 0.lµM of the inhibitor Y-27632 demonstrated 20.0 ± 5.6 podosome 
formation (Figure 11). A7r5 cells that were pretreated for 20 minutes with lnM of 
the inhibitor Y-27632 demonstrated 13.5 ± 4.86 % podosomes formation (Figure 11 ). 
It is apparent that Rho kinase inhibition prevents alpha actin remodeling in PDBu-
treated A7r5 cells. All three treatment concentrations were significantly different 
(p<.O 1) from PD Bu stimulated control cells that did not undergo Rho kinase 
inhibition. A typical result showing a-actin in a cell pretreated with lµM Y-27632 
and then stimulated with 10 -SM PD Bu is shown in the bottom right panel of figure 
12. 
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Figure 11: Podosome formation in A 7r5 cells pretreated with 1 µM, 0.1 µM , 1 nM of 
Y-27632 for twenty minutes before PDBu stimulation. Data is expressed 
as mean percent of cells undergoing cx-actin remodeling and podosome 
formation. (* represents significant difference p<.01 from vehicle 
controls, # represents significant difference (p<.01) from PDBu 
stimulated cells). 
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Control PDBu 10-SM, 20 min. 
PDBu 10-SM, 20 min. Y-27632 1 0µM, 20 min. 
Y-27632 10 M, 20 min. PDBu 10-SM 20 min. 
Figure 12: Micrograph comparing a-actin structure in a control cell (top left) and a 
cell that was treated with 10 -SM PD Bu for 20 minutes (top right) 
indicating remodeling of the a-actin cytoskeleton and podosome 
formation. Bottom panels demonstrate the effect of Rho-kinase 
inhibition after (left) and before (right) stimulation by PDBu. Original 
magnification at 400x. 
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Y-27632 induced loss ofpodosome structure in precontracted A7r5 
A 7r5 cells were stimulated with PDBu and then treated with Y-27632 to see 
. ' .. 
.. ' ' .. 
if Rho kinase inhibition would destroy the podosome· structure that was previously 
formed. The A7r5 cells were p~etreat~d PBDu··cio'8M, 20 niinutes) to stimulate actin 
remodeling and podosomes formation and then underwent exposure to lµM, 0.lµM, 
lnM of the Rho-kinase inhibitor Y-27632 following the 20 minute PDBu 
pretreatment. A7r5 cells that were pretreated for 20 minutes with PDBu then lµM of 
the inhibitor Y-27632 for 20 minutes demonstrated 18.1 ± 1.15 % podosomes (Figure 
13). A7r5 cells that were pretreated for 20 minutes with PDBu and then 0.lµM ofY-
27632 for 20 minutes demonstrated 13.3 ± 4.3 % podosomes (Figure 13). A7r5 cells 
that were pretreated for 20 minutes with PDBu following lnM of the inhibitor Y-
27632 demonstrated 13.3 ± 2.75% podosomes (Figure 13). This suggests that 
podosomes formation could not be maintained after the application of the inhibitor Y-
27632 for 20 minutes in all three concentrations. A typical cell is that was contracted 
with PDBu and then treated with l0µM Y-27632 is shown in the bottom left hand 
corner of Figure 12. 
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Figure 13: Podosome formation in A 7r5 cells pretreated with PDBu following 1 µM 
ofY-27632 for twenty minutes. Data is expressed as mean percent of 
cells undergoing a - actin remodeling and podosome formation. (* 
represents significant difference p<.O 1 from vehicle controls, # represents 
significant difference (p<.01) from PDBu stimulated cells). 
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Effect ofY-27632 on the alpha-actin cytoskeleton in a resting cell 
In order to determine if Rho kinase activity was required to maintain the 
cable-like alpha-actin structure observed in resting cells, Y-27632 (lµM, 40 minutes) 
was added to resting A7r5 cells (Figure 14). After forty minutes exposure to Y-
27632 the filamentous alpha-actin structure was lost and little evidence of cable 
structure was present (Figure 14). 
It was decided that a more thorough investigation of the effect ofY-27632 on 
the a-actin cytoskeleton. It was decided to use the lower concentration of 1 nM. 
A7r5 cells were exposed to Rho-kinase inhibitor for 5, 10, 20, 30, and 40 minutes and 
were then fixed and stained for a-actin (Figure 15). There was a loss of a-actin 
structure apparent after five minutes exposure with significant loss of cable structure 
after 30 minutes. At 40 minutes exposure there were very few cable structures 
remaining suggesting that Rho kinase is essential in the maintenance of filamentous 
a-actin structure. 
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Control Y-27632 10µm, 40 min. 
Figure 14: Micrograph comparing a-actin structure in a control cell (left) and 
a cell that was treated with 1 0rnM Y-27632 for 40 minutes (right) 
indicating loss of a-actin cables in a resting cell. Original 
magnification 400x. 
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Control 5 minutes 10 minutes 
20 minutes 30 minutes 40 minutes 
Figure 15: Time course illustrating the effect of Rho-kinase inhibition on 
resting A7r5 cells. Cells were exposed to lnM ofY-27632 for 
5, 10, 20, 30, and 40 minutes. Original magnification 400x. 
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DISCUSSION 
A model has been developed by Li et al., (2001) that describes how 
' ' 
remodeling of the cytoskeleton may explain the unique properties of force 
development and the maintenance of tension that occurs in smooth muscle (Figure 
16). The model proposes that a resting smooth muscle cell will contain inactive 
contractile proteins ( a-actin and myosin II) and ~-actin stress cables. Alpha-actin and 
smooth muscle specific myosin II exist as closely associated fibers in the resting cell 
(Fultz and Wright, 2003). Agonist stimulation will induce early force development 
by interaction of a-actin and myosin and subsequently introduce alteration in strain 
distribution, which will then lead to ~-actin remodeling to a shorter configuration that 
serves to hold the cell in the shortened configuration with the intention to preserve 
tension development during subsequent a-actin and myosin disassembly/reassembly. 
The reassembly of a-actin and myosin serves to optimize the overlap for additional 
contractile activity at the shortened length. This cycle of actin and myosin 
remodeling will continue during active force generation. The smooth muscle cell will 
plateau in force development and the formation of a stable system of tension bearing 
elements that will hold the cell in the shortened state with low expenditure of energy. 
This hypothesis is supported by observations of differential remodeling of alpha- and 
beta- actin (Fultz et al., 2000) and the localization of smooth muscle myosin with 
alpha-actin in the A7r5 smooth muscle cell (Fultz and Wright, 2003). 
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Figure 16. Model explaining force development and maintenance of active tension 
in smooth muscle (Li et al., 2001). 
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There has been a great interest in the role that actin has on cytoskeleton 
organization within smooth muscle contractile properties. Cytochalasins are a group 
of metabolites isolated from fungi (especially Helminthosporium dematioideum) that 
inhibit various cell processes (Carter, 1967). It was determined that the molecular 
mechanism of cytochalasins was through binding to the barbed or growing end of the 
actin filament, which would then prevent the addition of a subsequent monomer and 
prevent active actin remodeling (Cooper, 1987). Cytochalasins smooth muscle 
contraction affecting calcium currents, myosin light chain phosphorylation, or myosin 
ATPase activity within the K+ depolarized tissue (Obara and Y abu, 1994). 
Cytochalasin was used to inhibit actin polymerization and caused a 
. . 
selected blockage of a slow tension increase within rat aortic smooth muscle (Wright 
and Hurn, 1994). It was suggested by Wright and Hurn (1994) that for slow tension 
development to occur within smooth muscle, dynamic remodeling of a portion of the 
actin cytoskeleton must occurr during the contraction. This suggestion was supported 
(Mehta and Gunst, 1999) which showed an inhibition of actin polymerization by 
latrunculin-A, complexes with free monomers and will then lead to an inactivation of 
G-actin (Coue et al., 1987). This was found to lead to depressed force development 
without having an affect upon the myosin light chain phosphorylation, which would 
suggest that actin polymerization will contribute directly to force development. It 
was also shown that inhibition of actin polymerization will block calcium dependent 
stress relaxation within vascular smooth muscle, implicating possible active 
remodeling of the actin cytoskeleton which may decrease cellular tension following 
- 42-
an abrupt stretch (Wright and Battistella-Patterson, 1998). It has also been shown 
that actin is dynamic in resting tissue, with polymerization/depolymerization 
occurring and that stabilization may take place in the plateau of smooth muscle tissue 
undergoing contraction (Barney et al., 2001). All of this together leads to the 
suggestion that actin polymerization would be essential for contractile and stress 
relaxant properties of smooth muscle. Blocking of polymerization can not be credited 
to a simple loss in the structure of the cytoskeleton but would more likely be an 
accurate reflection of the inhibition on the dynamic actin cytoskeleton remodeling 
that occurs. 
The long-term goal of this project is to elucidate the biochemical 
mechanism(s) utilized by smooth muscle to regulate the drastic cytoskeletal 
remodeling that occurs during the contraction of smooth muscle. To begin this 
process, we have chosen to determine if Rho kinase inhibition will alter the dynamic 
a-actin remodeling that is observed in the PD Bu-stimulated A 7r5 cell. 
Rho kinase has been implicated in smooth muscle contraction, is distributed 
mainly within the cytoplasm, and when activated by GIP bound Rho-A 
will translocate from the cytoplasm to the membrane (Noma et al., 2005). Rho-kinase 
has a role in regulation of the cell contraction within smooth muscle cells, but has 
also been demonstrated to be critic:tl in controlling migrat\on, proliferation, cell 
apoptosis/survival, gene transcripti_on, and differentiat_ion (reviewed in Loirand et al., 
2006). The contraction of smooth n;mscle is dependent upon the balance between 
myosin light chain kinase and myosin phosphatase. Rho-kinase plays an important 
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role in the regulation ofmyosin phosphatase activity. RhoA and its downstream 
target Rho-kinase phosphorylate the myosin-binding subunit of myosin light chain 
kinase by phosphatase inhibition of the myosin light chain kinase(reviewed in Webb, 
2003). When Rho-kinase is inhibited with Y-27632 it will result in relaxation of 
isolated segments and smooth muscle contraction to many different agonists 
(reviewed in Webb, 2003). Within animal models, Rho-kinase has been used for 
treatment of the relaxation of the smooth muscle arteries, resulting in a blood pressure 
lowering effect (Chitaley et al., 2001 ). 
In this study we observed the effects of the Rho kinase inhibitor with Y-27632 
on the very specific remodeling of the a.-actin component of the cytoskeleton in the 
A 7r5 cell. In order to determine that our A 7r5 smooth muscle. cells were responsive 
to phorbol ester, cells were stimulated with 1 o·8M PDBu for 20 minutes. Over ninety 
percent of cells evaluated demonstrated a.-actin remodeling into podosomes. 
To test the hypothesis t~at Rho kinase is essential for proper a.-actin 
remodeling and podosomes formation, A7r5 smooth muscle cells were treated Y-
27632 at three concentrations (lµM, O.lµM, and lnM) for twenty minutes prior to 10· 
8M PD Bu stimulation. Results indicate that inactivation of Rho kinase prevented 
podosome formation and caused a general dissolution of alpha-actin cable structure 
was observed (Figures 11 ). This indicates that Rho kinase activity is required for 
podosome formation and that Rho kinase may be needed for a.-actin fiber 
maintenance. 
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We then wanted to determine if Rho kinase activity is required in the 
maintenance of podosomes in cells that are precontracted. Cells were stimulated with 
PDBu for twenty minutes to allow for remodeling and podosome formation and the 
effect of Rho kinase was examined by the addition of three different concentrations of 
Y-27632 (lµM, 0. lµM, and lnM) for twenty minutes. Cells were observed to 
undergo a loss of podosome structures and also a loss ofresidual stress cables. This 
further implicates the necessity for Rho kinase activity in the podosomes structure. 
Finally we wanted to observe the effect of inhibition of Rho kinase by Y-
27632 in the resting A7r5 smooth muscle cell line. Two concentrations ofY-27632 
were utilized in this experiment. A7i5 cells exposed to lµM Y-27632 for forty 
minutes demonstrated a drastic loss ofalpha-actin cable structure (Figure 13). We 
then pursued a more detailed time course with a reduced level ofY-27632 (lnM). 
Cells were exposed to lnM Y-27632 for 5, 10, 20, 30 and 40 minutes and 
representative micrographs are presented in Figure 15. At five minutes exposure, the 
disruption of the a.-actin cytoskeleton is observed with almost complete loss of cable 
structure by forty minutes exposure. This data suggests that Rho kinase is necessary 
for a.-actin bundling into its characteristic cable structure. 
This study has provided evidence that Rho-kinase may play a role in the 
signal transduction pathway that leads to a.-actin remodeling and podosome 
formation and maintenance in the contracting A7r5 smooth muscle cell. We conclude 
that Rho-kinase may play a critical role in a.-actin dynamics during contraction as 
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well as being necessary for F-actin structure in the cell. This has implications not 
only in the contraction of smooth muscle, but also in other physiological processes 
that require actin remodeling such as mitosis and cell crawling. Rho-kinase is 
implicated in actin dependent functions such as cell motility, formation of stress 
fibers, focal adhesions and smooth muscle contraction (Shabir et al., 2004). Data 
suggests (Shabir et al., 2004) that Rho-kinase may be involved as a signaling 
molecule that will activate a mechanism that will sensitize the contractile machinery 
to Ca2+. This study has provided information that Rho-kinase, present within the 
A 7r5 smooth muscle cell line, provides a role in smooth muscle contraction and 
maintenance of the contracted state at such a low energy concentration. 
Further experimentation should pursue the effect ofY-27632 on the P-actin 
cytoskeleton to determine if there is differential regulation of the two actin isoforms 
during smooth muscle contraction. Another future experiment would be to examine 
the effect of Rho-kinase inhibition by the inhibitor Y-27632 and the effect it has upon 
the G-actin and F-actin ratio within smooth muscle cells upon contraction. 
- 46-
LITERATURE CITED 
Alberts, B., A. Johnson., J. Lewis., M. Raf£, K. Roberts., P. Walter. "The 
Cytoskeleton." Molecular Biology Of The Cell. New York: Garland Science, 
2002. 961-968. 
Barany, M., J.T. Barron, L. Gu, and K. Barany. 2001. Exchange of the actin-bound 
nucleotide in intact arterial smooth muscle. J. Biol. Chem. 276:48398-48403. 
Brandt, D., M. Gimona, M. Hillmann, H. Haller, and H. Mischak. 2002. Protein 
kinase C induces actin reorganization via a Src-and Rho-dependent pathway. 
J. Biol. Chem. 23:20903-20910. 
Cartier, M.F., and D. Pantaloni. 2007. Control of actin assembly dynamics in cell 
motility. J. Biol. Chem. 282:23005-23009. 
Carter, S.B. 1967. Effects of cytochalasins on mammalian cells. Nature. 213:261-. 
264. 
Chellaiah, M., C. Fitzgerald., U. Alvarez., and K. Hruska. 1998. c-Src is required for 
stimulation of gelsolin-associated phosphatidylinositol 3-kinase. J. Biol. 
Chem. 273:11908-11916. 
Chitaley, K., D. Weber, and R. Webb. 2001. RhoA/Rho-kinase, vascular changes, 
and hypertension. Curr. Hypertens Rep. 2:139-144. 
Cooper, J.A. 1987. Effects ofcytochalasin and phalloidin on actin. J. Cell Biol. 
105:1473-1488. 
Coue, M., S.L. Brenner, I. Spector, and E.D. Korn. 1987. Inhibition of 
Actin polymerization by latrunculin A. FEBS Letters. 213:316-318. 
Driska, S.P., M.O. Aksoy, and R.A. Murphy. 1981. Myosin light chain 
phosphorylation associated with contraction in arterial smooth muscle. 
Am. J. Physiol. 240:C222-C233. 
Fultz, M.E., C. Li., W. Geng., and G.L. Wright. 2000. Remodeling of the actin 
cytoskeleton in contracting A 7r5 smooth muscle cell. J. Muse. Res. Cell 
Motil. 6:521-534. 
Fultz, M.E., and G. Wright. 2003. Myosin remodeling in the contracting A7r5 
smooth muscle cell. Act. Physiol. Scand. 2:187-205. 
-47 -
Gerthoffer, W.T., and S.J. Gunst. 2001. Signal transduction in smooth muscle 
invited review: focal adhesion and small heat shock proteins in the regulation 
ofactin remodeling and contractility in smooth muscle. J. Appl. Physiol. 
91:963-972. 
Hai, C-M. and R.A. Murphy. 1989. Cross-bridge dephosphorylation and relaxation 
in vascular smooth muscle. Am. J. Physiol. 256:C282-C287. 
Ishizaki, T., M. Uehata., I. Tamechika., J. Keel., K. Nonomura., M. Maekawa., S. 
Narumiya. Pharmacological properties ofY-27632, a specific inhibitor of 
rho-associated kinases. Am. Soc. Pharm. Exp. Therapeutics. 57:976-983. 
Kaverina, I., T. Strada!., and M. Gimona. 2003. Podosome formation in cultured 
A 7r5 vascular smooth muscle cells requires Arp2/3-dependent denovo actin 
polymerization at discrete microdomains. J. Cell. Sci. 116:4915-492. 
Li, C., M. Fultz., J. Parkash., W. Rhoten., and G. Wright. 2001. Ca2+ dependent 
actin remodeling in the contracting A 7r5 cell. Muscle Research and Cell 
Motility. 22:521-534. 
Linder, S., and P. Kopp. 2005. Podosomes at a glance. J. Cell. Sci. 118:2079-2082. 
Loirand, G., P. Guerin., and P. Pacaud. 2006. Rho-kinases in cardiovascular 
physiology and pathophysiology. J. Am. Heart Assoc. 93:322-334. 
Marston, S.B., and C.W. J. Smith. 1985. The thin filaments of smooth muscles. J. 
Muse. Rec. Cell. Motil. 6:669-108. 
McComas, A. "Muscle Contraction." Skeletal Muscle Form and Function. 
Champaign: Human Kinetics. 1996. 161-183. 
Mehta, D. and S.J. Gunst. 1999. Actin polymerization stimulated by contractile 
activation regulates force development in canine tracheal smooth muscle. J. 
Physiol. (Lond). 519(3):829-840. 
Merkel, L., W.T. Gerthoffer, and T.J. Torphy. 1990. Dissociation between myosin 
phosphorylation.and shortening velocity in canine trachea. Am. J. Physiol. 
258:C524-C532. 
~ ... .· 
Murphy, R.A. 1976. Contractile system function in mammalian smooth muscle. 
Blood Vessels. 13, 1-23. 
-48 -
Murphy, R.A., J.T. Herliky, and J. Meyerman. 1974. Force-generating capacity and 
contractile protein content of arterial smooth muscle. J. Gen. Physiol. 64, 
691-705. 
Nakajima, S., M. Fujmoto, M. Veda. 1993. Spatial changes of [Ca2l and contraction 
caused by phorbol esters in vascular smooth muscles. Am. J. Physiol. 265( 4): 
Cl 138-Cl 145. 
Noma, K., N. Oyama., and J.K. Liao. 2006. Physiological role ofROCKs in the 
cardiovascular system. Am. J. Physiol. Cell Physiol. 290:661-668. 
Ohara, K. and H. Y abu. 1994. Effect of cytochalasin B on intestinal smooth muscle 
cells. Eur. J. Pharm. 255:139-147. 
Paul, R.J. 1983. Functional compartmentalization of oxidative and glycolytic 
metabolism in vascular smooth muscle. Am. J. Physiol. 244-C399-C409. 
Rodriguez-Fernandez, J., L. Sanchez-Martin., M. Rey., M. Vicente-Manzanares., 
S. Narumiya., J. Teixido., F. Sanchez-Madrid and c. Cabanas. 2001. Rho and 
Rho-associated kinase modulate the tyrosine kinase PYK2 in T-cells through 
regulation of the activity of the integrin LFA-1. J. Biol. Chem. 44:40518-
40527. 
Schloss, J.A., and R.D. Goldman. 1979. Isolation of high molecular weight 
actin-binding protein from baby hamster kidney (BHK-21) cells. 
Proc. Natl. Acad. Sci. USA. 76:4484-4488. 
Shabir, S., L. Borisova., S. Wray., and T. Burdyga. 2004. Rho-kinase inhibition and 
electromechanical coupling in phasic smooth muscle; Ca2+ dependent and 
independent mechanisms. J. Phys. 560.3:839-855. 
Shaw, L., S. Ahmed., C. Austin., and M.J. Taggart. 2002. Inhibitors of actin filament 
polymerization attenuate force but not global intracellular calcium in isolated 
pressurized resistance arteries. J. V asc. Res. 40: 1-10. 
Starr, C., and R. Taggart. "Muscle Tissue." Biology The Unity and Diversity of Life. 
Pacific Grove: Brooks/Cole, 2001. 566. 
Thyberg, J., J. Nilsson., L. Palmberg., M. Sjolund. 1985. Adult human arterial 
smooth muscle cells in primary culture: modulation from contractile to 
synthetic phenotype. Cell. Tiss. Res. 239:69-74. 
- 49 -
Wang, P., and K.N. Bitar. 1998. Rho A regulates sustained smooth muscle 
contraction through cytoskeletal reorganization ofHSP27. Am. Physiol. Soc. 
G:1454-1462. 
Webb, R. 2003. Smooth muscle contraction and relaxation. Advan. Physiol. Educ. 
27: 201-206. 
Wright, G., and P. Battistella. 1998. Involvement of the cytoskeleton in calcium-
dependent stress relaxation ofrat aortic smooth muscle. J. Muscle Res. Cell 
Motility 4:405-414. 
Wright, G., and E. Hum. 1994. C)'tochalasin inhibition of slow tension increase in 
rat aortic rings. Am. J. Physiol. 267(36). Hl437-H1447. 
Yin, H., and J.T. Stull. 1999. Proteins that regulate dynamic actin remodeling in 
response to membrane signaling minireview series. J. Biol. Chem. 
274:32529-32530. 
Zhang, Y., and R.S. Moreland. 1994. Regulation ofCa2+-dependent ATPase activity 
in detergent skinned vascular smooth muscle. Am. J. Physiol. 36:Hl032-
H1039. 
